C12Y 106/99003
Nadh dehydrogenase
Official title: NADH dehydrogenase (1.6.99.3)
C12Y106/99003 (Nadh dehydrogenase) appears on 16 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 25
- Assignees
- 21
- Inventors
- 57
- Latest grant
- 7 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 3 | 6 |
| 2022 | 5 | 3 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant host cells and methods for the production of glyceric acid and downstream products7 Jan 2025US 12,188,008 B2Lygos, Inc.
- Microorganisms and processes for lactic acid production20 Sep 2022US 11,447,802 B2PTT Global Chemical Public Company Limited
- Biosensor for detecting TNT23 Aug 2022US 11,421,236 B1Research Foundation of the City University of New York
- Compositions and methods for treating leber's hereditary optic neuropathy with NADH dehydrogenase proteins14 Jun 2022US 11,357,869 B2Wuhan Neurophth Biotechnology Limited Company
- Compositions and methods for treating Leber's hereditary optic neuropathy7 Jun 2022US 11,352,645 B2Wuhan Neurophth Biotechnology Limited Company
- Biological devices for enhancing nad production and activity, methods of making the same, and methods of using the same to enhance protein and peptide production20 Aug 2026US 2026/0242807 A1Bio Capital Holdings, LLC
- Recombinant host cells and methods for the production of glyceric acid and downstream products30 Oct 2025US 2025/0333686 A1Lygos, Inc.
- Compositions and methods for treating leber's hereditary optic neuropathy27 Oct 2022US 2022/0340895 A1
- Compositions and methods for treating leber's hereditary optic neuropathy with nadh dehydrogenase proteins1 Sep 2022US 2022/0273816 A1Wuhan Neurophth Biotechnology Limited Company
- Compositions and methods for treating leber's hereditary optic neuropathy18 Aug 2022US 2022/0259619 A1Wuhan Neurophth Biotechnology Limited Company
Most cited
By later US patents
- Adeno-associated virus-delivered ribozyme compositions and methods of use8US 7,342,111 B2University of Florida Research Foundation, Inc. · 2008
- Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes6US 6,071,743 ASubsidiary No. 3, Inc. · 2000
- Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes6US 6,537,972 B1Subsidiary No. 3, Inc. · 2003
- Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes5US 6,326,152 B1Subsidiary No. 3, Inc. · 2001
- Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes5US 6,436,634 B1Subsidiary No. 3, Inc. · 2002